SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-094337
Filing Date
2023-04-07
Accepted
2023-04-06 20:58:08
Documents
20
Period of Report
2023-04-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d494893d8k.htm   iXBRL 8-K 34927
2 EX-5.1 d494893dex51.htm EX-5.1 9486
3 EX-10.1 d494893dex101.htm EX-10.1 202129
4 EX-10.2 d494893dex102.htm EX-10.2 77884
5 EX-10.3 d494893dex103.htm EX-10.3 33828
6 EX-10.4 d494893dex104.htm EX-10.4 5499
7 EX-99.1 d494893dex991.htm EX-99.1 8046
12 GRAPHIC g494893dsp51.jpg GRAPHIC 8006
  Complete submission text file 0001193125-23-094337.txt   643874

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA celu-20230404.xsd EX-101.SCH 3855
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE celu-20230404_def.xml EX-101.DEF 13634
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE celu-20230404_lab.xml EX-101.LAB 22547
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE celu-20230404_pre.xml EX-101.PRE 14602
14 EXTRACTED XBRL INSTANCE DOCUMENT d494893d8k_htm.xml XML 5334
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

IRS No.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 23807610
SIC: 2834 Pharmaceutical Preparations